Huons Co., Ltd. (243070.KQ)

KRW 28400.0

(1.79%)

Revenue Summary of Huons Co., Ltd.

Huons Co., Ltd.'s latest annual revenue in 2023 was 552 Billion KRW , up 12.11% from previous year.
Huons Co., Ltd.'s latest quarterly revenue in 2024 Q1 was 147.76 Billion KRW , up 1.75% from previous quarter.
Huons Co., Ltd. reported a annual revenue of 492.38 Billion KRW in annual revenue 2022, up 12.7% from previous year.
Huons Co., Ltd. reported a annual revenue of 436.91 Billion KRW in annual revenue 2021, up 7.43% from previous year.
Huons Co., Ltd. reported a quarterly revenue of 148.98 Billion KRW for 2024 Q2, up 0.83% from previous quarter.
Huons Co., Ltd. reported a quarterly revenue of 140.69 Billion KRW for 2023 Q2, up 9.99% from previous quarter.

Annual Revenue Chart of Huons Co., Ltd. (2023 - 2014)

Historical Annual Revenue of Huons Co., Ltd. (2023 - 2014)

Year	Revenue	Revenue Growth
2023	552 Billion KRW	12.11%
2022	492.38 Billion KRW	12.7%
2021	436.91 Billion KRW	7.43%
2020	406.67 Billion KRW	11.41%
2019	365.01 Billion KRW	11.08%
2018	328.59 Billion KRW	15.36%
2017	284.83 Billion KRW	68.58%
2016	168.96 Billion KRW	0.0%
2014	182.34 Billion KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q1	147.76 Billion KRW	1.75%
2024 Q2	148.98 Billion KRW	0.83%
2023 Q2	140.69 Billion KRW	9.99%
2023 FY	552 Billion KRW	12.11%
2023 Q4	145.22 Billion KRW	5.11%
2023 Q1	127.91 Billion KRW	-1.08%
2023 Q3	138.16 Billion KRW	-1.8%
2022 Q2	124.07 Billion KRW	7.08%
2022 Q4	129.31 Billion KRW	5.02%
2022 Q3	123.12 Billion KRW	-0.76%
2022 Q1	115.86 Billion KRW	1.88%
2022 FY	492.38 Billion KRW	12.7%
2021 Q2	111.13 Billion KRW	11.37%
2021 FY	436.91 Billion KRW	7.43%
2021 Q1	99.78 Billion KRW	-2.62%
2021 Q4	113.73 Billion KRW	1.31%
2021 Q3	112.25 Billion KRW	1.01%
2020 Q3	106.04 Billion KRW	2.38%
2020 Q1	94.57 Billion KRW	-6.14%
2020 Q2	103.57 Billion KRW	9.52%
2020 FY	406.67 Billion KRW	11.41%
2020 Q4	102.47 Billion KRW	-3.37%
2019 Q2	86.64 Billion KRW	4.88%
2019 FY	365.01 Billion KRW	11.08%
2019 Q4	100.76 Billion KRW	6.09%
2019 Q3	94.98 Billion KRW	9.62%
2019 Q1	82.62 Billion KRW	-6.28%
2018 FY	328.59 Billion KRW	15.36%
2018 Q2	80.13 Billion KRW	8.24%
2018 Q3	86.26 Billion KRW	7.65%
2018 Q1	74.03 Billion KRW	1.35%
2018 Q4	88.15 Billion KRW	2.19%
2017 Q1	65.18 Billion KRW	-56.58%
2017 FY	284.83 Billion KRW	68.58%
2017 Q4	73.05 Billion KRW	-1.92%
2017 Q3	74.48 Billion KRW	3.28%
2017 Q2	72.11 Billion KRW	10.63%
2016 Q3	62.01 Billion KRW	0.0%
2016 FY	168.96 Billion KRW	0.0%
2016 Q4	150.14 Billion KRW	142.11%
2014 FY	182.34 Billion KRW	0.0%

Peer Revenue Comparison of Huons Co., Ltd.

Name	Revenue	Revenue Difference
HLB Pharmaceutical Co., Ltd	135.95 Billion KRW	-306.028%
CMG Pharmaceutical Co., Ltd.	93.9 Billion KRW	-487.825%
Celltrion Pharm, Inc.	388.79 Billion KRW	-41.979%
Huons Global Co., Ltd.	758.37 Billion KRW	27.212%
DongKook Pharmaceutical Co., Ltd.	730.99 Billion KRW	24.485%
Enzychem Lifesciences Corporation	76.03 Billion KRW	-625.953%
Humedix Co., Ltd.	152.27 Billion KRW	-262.509%
Boditech Med Inc.	134.21 Billion KRW	-311.272%
EuBiologics Co., Ltd.	69.36 Billion KRW	-695.792%
FutureChem Co.,Ltd	13.96 Billion KRW	-3851.932%
BNC Korea Co., Ltd.	80.99 Billion KRW	-581.511%
AptaBio Therapeutics Inc.	323.86 Million KRW	-170341.386%